REVITALIZING WOMEN’S HEALTH: Why Hormone Replacement Therapy Matters — And Whats Changed
By Dr. Glen Brooks, Spa on the Green
Published in Longmeadow Neighbors | January 2026
As women transition through menopause, the body’s natural production of estrogen and progesterone declines. These hormonal changes can trigger a wide array of symptoms — hot flashes, night sweats, sleep disruptions, mood shifts, vaginal dryness, and bone loss. These symptoms can be disruptive to the everyday quality of life.
Hormone replacement therapy (HRT) offers a powerful way to restore hormonal balance, alleviating menopausal symptoms and improving long-term health. Research shows that, when appropriately prescribed, HRT can do more than just offer symptom relief: it may reduce the risk of bone fractures, support cardiovascular health, and even provide cognitive benefits.
Many women have shied away from hormone therapy due to long-standing safety warnings. For more than twenty years, HRT products carried “black box” warnings from the FDA — the agency’s most serious label — indicating heightened risk of cardiovascular disease, breast cancer, dementia, and other issues. These warnings were based primarily on early data from the Women’s Health Initiative, which studied older hormone formulations in women above age 60, and the conclusions were overly generalized.
In a landmark decision announced in November 2025, the FDA began the removal of these broad black box warnings from many HRT products. This move came after a comprehensive review of the scientific literature, public comment, and input from expert panels.
Key changes to the labeling include the removal of warnings about cardiovascular disease, breast cancer, and dementia for many systemic hormone therapies. The FDA continues to recommend that systemic HRT be started within 10 years of the onset of menopause or before age 60 — when the benefits appear to be especially strong. Importantly, the boxed warning for endometrial cancer remains on estrogen-only products for women who still have a uterus. These women benefit from the addition of progesterone to reduce that risk.
While some risk remains (for instance, certain forms or routes of estrogen can carry small risks of blood clots), experts say the new labeling better reflects a more science-based understanding of benefit versus risk.
Dr. Glen Brooks
PLASTIC SURGERY & MEDICAL SPA
Spa on the Green
413-565-4400
drglenbrooks.com
For too long, fear from outdated warnings prevented many women, and their physicians, from considering HRT, even when the benefits might outweigh the risks. As FDA Commissioner Marty Makary put it: women should make decisions about HRT “based on data, not fear.” The updated approach empowers patients and providers to have more informed, individualized conversations about whether HRT is right.
With this regulatory shift, we are excited to announce that our office is trained to offer comprehensive individual HRT consultations and treatment for women. Our approach is personalized: we evaluate each patient’s health history, symptoms, labs, timing, and risk factors. We will then talk candidly about the benefits and risks, as well as strategies to monitor and mitigate them.
If you’ve been struggling with menopausal symptoms, or if you’ve previously shied away from hormone therapy because of safety concerns — now may be the time to revisit the conversation. We invite you to schedule a consultation with our expert, Lauren Wheeler PA-C, a certified BHRT provider to explore whether HRT could be a beneficial and safe option for you.
Other Articles in this Issue
